|
|
Article: Panelists debate implications of new drug-eluting stents.
- Article from:
- Medical Device Daily
- Article date:
- May 14, 2003
CopyrightCOPYRIGHT 2003 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Panelists debate implications of new drug-eluting stents
By KEVIN NEW
Medical Device Daily Washington Editor
WASHINGTON Drug-eluting stents are now becoming a reality in the daily practices of physicians nationwide, but the touted technology isnt getting a warm reception in the nations hospital boardrooms.
The FDAs recent approval of the Cypher stent from Johnson & Johnsons Cordis (Miami Lakes, Florida) subsidiary has the effect of a perfect storm for healthcare providers, said Bruce Chandler, executive vice president of Saint Josephs Health System (Atlanta, Georgia). Chandler was one of three panelists during a recent webcast ...